Loading CV, please wait...

CURRICULUM VITAE

DR. MOHD AIZUDDIN BIN MOHD ZULASTRI
DR. MOHD AIZUDDIN BIN MOHD ZULASTRI
Medical Lecturer
Department of Medicine
Faculty of Medicine
0379492429
ResearcherID
Scopus Author ID
ORCID ID

ACADEMIC QUALIFICATION

  • MIM, (INTERNAL MEDICINE)
    Universiti Malaya (UM)
  • MBBS, (Medicine and Surgery)
    Universiti Malaya (UM)

PUBLICATIONS

Article in Journal
WoS
  1. Sheikha, SSS; Aseri, MA; Zulastri, MAM; Ismail, IN; Abidin, IZ (2026). Idiopathic left anterior fascicular tachycardia-The misunderstood rhythm, INTERNATIONAL JOURNAL OF CARDIOLOGY. 455, 2. doi:10.1016/j.ijcard.2026.134389
  2. Aseri, Muhammad Azlan; Zulastri, Mohd Aizuddin Mohd; Sheikh, Syed Saleh Syed; Zuhdi, Ahmad Syadi Mahmood; Abidin, Imran Zainal (2025). Optimizing Complex PCI Outcomes in Calcified Coronary Disease Using Intravascular Imaging, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 85(15), S169-S170
  3. Sheikh, Syed Saleh Syed; Rupeng, New; Aseri, Muhammad Azlan; Zulastri, Mohd Aizuddin Mohd; Matsuo, Koshi; Ahmad, Wan Azman Wan; Zuhdi, Ahmad Syadi Mahmood; Wei, Lee Kee (2025). Chronic Total Occlusion of Left Anterior Descending Artery: A Case Report of Antegrade Approach With Usage of Dual Lumen Microcatheter With Buddy Wire Support, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 85(15)
  4. Zulastri, Mohd Aizuddin Mohd; Aseri, Muhammad Azlan; Sheikh, Syed Saleh Syed; Zuhdi, Ahmad Syadi Mahmood; Abidin, Imran Zainal (2025). Recurrent Acute Total Occlusion of the Right Coronary Artery Managed With Thrombus Aspiration and Stenting: A Case Report With Discussion on Revascularizat ion Strategies, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 85(15)
  5. Aseri, M. A.; Mashood, F.; Zulastri, M. A.; Sheikh, S. S. S.; Zuhdi, A. S. M. (2024). Predictive values of lipid markers in assessing severity of atherosclerotic plaque burden in patients presented with acute coronary syndrome, INTERNATIONAL JOURNAL OF CARDIOLOGY. 417. doi:10.1016/j.ijcard.2024.132802
  6. Mashood, F.; Aseri, M. A.; Zulastri, M. A.; Sheikh, S. S. S.; Zuhdi, A. S. M. (2024). Assessment of remnant cholesterol levels in acute coronary syndrome patients and its implication to lipid-reduction strategy: Findings from a tertiary centre, INTERNATIONAL JOURNAL OF CARDIOLOGY. 417. doi:10.1016/j.ijcard.2024.132765
  7. Sheikh, S. S. S.; Anuar, N. K.; Aseri, M. A.; Zulastri, M. A. M.; Mashood, F.; Za, Imran (2024). Heart failure mortality across the heart failure spectrum: An overview of heart failure registry of University Malaya Medical Centre (UMMC), INTERNATIONAL JOURNAL OF CARDIOLOGY. 417. doi:10.1016/j.ijcard.2024.132773
ESCI
  1. Zulastri, MAM; Aseri, MA; Sheikh, SSS; Abidin, IZ (2026). Sinus Pause and Cognitive Dysfunction: Diagnostic and Therapeutic Implications, CLINICAL CASE REPORTS. 14, 6. doi:10.1002/ccr3.72940
Scopus
  1. Zulastri, M. A. M., Hafidz, M. I., Ismail, M. D., & Zuhdi, A. S. M. (2021). Hematocrit change as a predictor of readmission for decompensated heart failure: A retrospective single centre study. Reviews in Cardiovascular Medicine, 22(2), 505-512. doi: 10.31083/j.rcm2202058
Others
  1. Mohd Zulastri, M.A., Aseri, M.A., Syed Sheikh, S.S. et al. Subacute normotensive cardiac tamponade as the initial presentation of metastatic lung adenocarcinoma: a case report. J Med Case Reports (2026). https://doi.org/10.1186/s13256-026-06173-x
Article in Proceeding
  1. Aizuddin, M. M., Azlan, A. M., Saleh, S. S., & Imran, Z. (2025). APCU 04 Electroconvulsive therapy-induced Generalized T - wave inversion. Openheart, A2.1-A2. https://doi.org/10.1136/openhrt-2024-apcu.4
  2. Aizuddin, M. M., Azlan, A. M., Saleh, S. S., & Syadi, M. A. (2025). APCU 03 Association of iron deficiency with clinical severity and atherosclerotic plaque burden in patients Presented with ST-elevation myocardial infarction. Openheart, A1.3-A2. https://doi.org/10.1136/openhrt-2024-apcu.3

RESEARCH PROJECT

Private
  1. 2025 - 2028, CPC CLINICAL RESEARCH
    RANDOMIZED TRIAL TO DETERMINE THE EFFICACY AND SAFETY OF FINERENONE ON MORBIDITY AND MORTALITY AMONG HEART FAILURE PATIENTS WITH LEFT VENTRICULAR EJECTION FRACTION GREATER THAN OR EQUAL TO 40% HOSPITALIZED DUE TO AN EPISODE OF ACUTE DECOMPENSATED HEART FAILURE (REDEFINE-HF) ( Co-Researcher)
  2. 2024 - 2027, NOVO NORDISK PHARMA (MALAYSIA) SDN. BHD.
    THE CARDIOVASCULAR SAFETY AND EFFICACY OF CAGRILINTIDE 2.4 MG S.C. IN COMBINATION WITH SEMAGLUTIDE 2.4 MG S.C. (CAGRISEMA 2.4 MG/2.4 MG S.C.) ONCE-WEEKLY IN PARTICIPANTS WITH ESTABLISHED CARDIOVASCULAR DISEASE. ( Co-Researcher)
  3. 2025 - 2027, ANTHOS THERAPEUTICS
    A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABELACIMAB IN HIGH-RISK PATIENTS WITH ATRIAL FIBRILLATION WHO HAVE BEEN DEEMED UNSUITABLE FOR ORAL ANTICOAGULATION (LILAC) ( Co-Researcher)
  4. 2024 - 2027, JANSSEN RESEARCH & DEVELOPMENT, LLC
    A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO DEMONSTRATE THE EFFICACY AND SAFETY OF MILVEXIAN, AN ORAL FACTOR XIA INHIBITOR, AFTER A RECENT ACUTE CORONARY SYNDROME ( Co-Researcher)
  5. 2025 - 2027, Viatris Innovation GmBH
    Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction. ( Co-Researcher)
  6. 2024 - 2026, NOVO NORDISK PHARMA (MALAYSIA) SDN. BHD.
    ATHENA: EFFECTS OF ZILTIVEKIMAB VERSUS PLACEBO ON HEART FAILURE SYMPTOMS AND PHYSICAL FUNCTION IN PATIENTS WITH HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION AND SYSTEMIC INFLAMMATION ( Co-Researcher)
  7. 2024 - 2026, NOVO NORDISK PHARMA (MALAYSIA) SDN. BHD.
    ARTEMIS - EFFECTS OF ZILTIVEKIMAB VERSUS PLACEBO ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ( Co-Researcher)
  8. 2024 - 2026, NOVO NORDISK PHARMA (MALAYSIA) SDN. BHD.
    ARTEMIS - EFFECTS OF ZILTIVEKIMAB VERSUS PLACEBO ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ( Co-Researcher)
  9. 2024 - 2025, QUESTRA CLINICAL RESEARCH SDN BHD
    EVALUATION OF EFFECTIVENESS AND THERAPEUTIC RESPONSE TO VASTAREL 80 OD IN DAILY PRACTICAL USE FOR CHRONIC STABLE ANGINA PECTORIS (V-GOOD) ( Co-Researcher)
International
  1. 2023 - 2027, NOVO NORDISK PHARMA (MALAYSIA) SDN. BHD.
    HERMES: EFFECTS OF ZILTIVEKIMAB VERSUS PLACEBO ON MORBIDITY AND MORTALITY IN PATIENTS WITH HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION AND SYSTEMIC INFLAMMATION. ( Co-Researcher)
  2. 2025 - 2026, IONIS PHARMACEUTICALS, INC.
    AN OPEN-LABEL EXTENSION STUDY OF OLEZARSEN (ISIS 678354) ADMINISTERED SUBCUTANEOUSLY TO PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SHTG) ( Co-Researcher)
  3. 2023 - 2025, MONASH UNIVERSITY
    GUIDELINE ORIENTED APPROACH TO LIPID LOWERING IN ASIA-PACIFIC (GOAL-ASIA) ( Co-Researcher)
  4. 2023 - 2025, IONIS PHARMACEUTICALS, INC.
    A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY OF OLEZARSEN (ISIS 678354) ADMINISTERED SUBCUTANEOUSLY TO PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA ( Co-Researcher)
University
  1. 2025 - 2026, University Grant
    Heart Failure Knowledge Assessment and Perceived Patient Satisfaction in Heart Failure Patients: A Cross -Sectional Study ( Principal Investigator(PI))
  2. 2025 - 2026, University Grant
    Epidemiological Profile of Patients with Acute Coronary Syndrome: Single-Center Experience ( Co-Researcher)

SUPERVISION

Postgraduate Student
  1. (2026) READMISSION RATES AND PREDICTORS WITHIN 30 DAYS POST-DISCHARGE AMONG HEART FAILURE PATIENTS AT UNIVERSITI MALAYA MEDICAL CENTRE, NUR FASEHAH BINTI MD NAZRI
Under Graduate Students
  1. (2026) Elective Posting from 2/2/2026 - 20/3/2026
  2. (2026) Practices
  3. (2024) UMMP PRE-INTERNSHIP PROGRAMME (PRINT)
  4. (2024) Practices, Mohammad Qalish Bin Mohd Hashim, Nurin Imanina Binti Mohamed Shafri, Reshgi Vaishali A/P Lactmanan @ Rajan, Joshua Jeyaraj Jeremiah, Bong Yun Lin, Shamalan A/L Santhiran
  5. (2023) Elective Posting for Final Year Medical Student